Since the Foundation was created, 18 prizes have been awarded.
The latest one has been awarded in 2023.
Exploiting the pathophysiology of the gut towards innovative treatments for gastrointestinal/metabolic diseases.
Repurposing the antidepressant sertraline to target serine/glycine synthesis addicted cancer.
Detecting Alzeimher’s pathology before memory decline using new radiopharmaceuticals
The role of coagulates in invasive staphylococcus aureus infections.
Frontotemporal dementia caused by Progranulin mutations, treatable neurodegenerative disorders?
Pharmacological modulation of glial glutamate uptake: manipulating the cross-talks between neuroinflammation and excitotoxicity to treat neurological disorders.
Role and Therapeutic Potential of VEGF in Motor Neuron Degeneration : a Study in Transgenic Mice and Rats.
Contribution du CYP3A intestinal dans la métabolisation du midazolam chez le rat.
The Physiology, pharmacology and therapeutic potential of 5 – HT1 receptors in the gastro intestinal tract.
Leukotrienes
Contribution to the development of an effective antiplatelet drug.
Détermination des shunts porto-systémiques chez l’homme par un test non invasif au d-propylène.
Pharmacologie clinique de l’induction de l’inhibition enzymatique chez des sujets hydroxylateurs déficients.
Pharmacokinetic drug interactions in man.
Pharmacocinétique du Fénofibrate – Contribution à l’étude de sa pharmacologie clinique.
Etude pharmacocinétique de la Daunorubicine libre et complexé à l’ADN chez le lapin et en clinique humaine.
Repurposing the antidepressant sertraline to target serine/glycine synthesis addicted cancer.
Psychopharmacological research versus treatment.